Study to Evaluate the Efficacy and Safety of ORAVESCENT Fentanyl Citrate for the Management of Breakthrough Pain
Public ClinicalTrials.gov record NCT00214955. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ORAVESCENT Fentanyl Citrate for the Management of Breakthrough Pain in Opioid-Tolerant Patients With Chronic Neuropathic Pain
Study identification
- NCT ID
- NCT00214955
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Cephalon
- Industry
- Enrollment
- 120 participants
Conditions and interventions
Conditions
Interventions
- ORAVESCENT Fentanyl Citrate Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 31, 2005
- Primary completion
- Apr 30, 2006
- Completion
- Not listed
- Last update posted
- May 8, 2014
Started 2005
United States locations
- U.S. sites
- 17
- U.S. states
- 11
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clopton Clinic | Jonesboro | Arkansas | 72401 | — |
| Vertex Clinical Research, Inc. | Bakersfield | California | 93311 | — |
| San Diego Arthritis Medical | San Diego | California | 92106 | — |
| Clinical Research of W Florida | Clearwater | Florida | 33765 | — |
| Florida Institute of Medical R | Jacksonville | Florida | 32207 | — |
| Clinical Pharmacology Services | Tampa | Florida | 33617 | — |
| Gold Coast Research | Weston | Florida | 33331 | — |
| Center for Prospective Outcome | Marietta | Georgia | 30060 | — |
| Georgia Medical Research | Marietta | Georgia | 30060 | — |
| American Medical Research | Chicago | Illinois | 60616 | — |
| American Medical Research | Oak Brook | Illinois | 60523 | — |
| American Medical Research | Valparaiso | Indiana | 46383 | — |
| Iowa Pain Management Clinic, P | Des Moines | Iowa | 50265 | — |
| Mid America Physiatrists, PA | Overland Park | Kansas | 66211 | — |
| Best Clinical Trial, Inc. | New Orleans | Louisiana | 70115 | — |
| PharmQuest | Greensboro | North Carolina | 27401 | — |
| Northwest Clinical Research | Bellevue | Washington | 98004 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00214955, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 8, 2014 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00214955 live on ClinicalTrials.gov.